Mayinglong Pharmaceutical Group Co., Ltd.

¥25.05As of Sun 8 Nov 2026, 12:00 UTC
SSE:600993Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 3.61%
Div yield 2.79%
ROE 13.56%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.15
PE TTM 18.15
TSR TTM (8.64%)
Mkt cap ¥10.80B
ROIC 25.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
1.63%
0.81%
Buy 9|2|5|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.40
0.39
0.37
0.36
21.05%
5.56%
(3.55%)
(10.29%)
Revenue¥M
736.5
752.3
792.1
795.8
9.30%
12.59%
15.68%
13.78%
Peers (US$1.619B)
Cap (US$)
PE
1.629B
51.47x
1.622B
23.44x
1.622B
97.95x
Capital
TTM
5Y
10Y
Leveragex
0.888
(0.280)
(0.205)
EBIT/Intx
0.091
0.129
0.154
Own earn%
3.55
169.19
160.56
Sh yield%
28.59
17.70
19.37
Owners
Insiders/Inst%
7.26
71.26
Short interest%
1.66
SBC / revenue%
5.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
18–27
$1 testx
—
Incr. ROIC%
11